Search Results - "ONAT, Haluk"

Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial by Dogliotti, Luigi, Cartenì, Giacomo, Siena, Salvatore, Bertetto, Oscar, Martoni, Andrea, Bono, Aldo, Amadori, Dino, Onat, Haluk, Marini, Luca

“…Abstract Objectives This phase 2 randomized study compared the toxicity and assessed the efficacy of gemcitabine–cisplatin (GP) and gemcitabine–carboplatin…”
Get full text

Medical oncologist: A warrior against cancer, fully equipped by Onat, Haluk

Get full text

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients by Baujat, Bertrand, Audry, Hélène, Bourhis, Jean, Chan, Anthony T C, Onat, Haluk, Chua, Daniel T T, Kwong, Dora L W, Al-Sarraf, Muhyi, Chi, Kwan-Hwa, Hareyama, Masato, Leung, Sing F, Thephamongkhol, Kullathorn, Pignon, Jean-Pierre

“…To study the effect of adding chemotherapy to radiotherapy (RT) on overall survival and event-free survival for patients with nasopharyngeal carcinoma. This…”
Get more information

Clinical Outcome of Rhabdomyosarcoma in Adolescent and Adult Patients: Single Center Experience from Turkey by Ustuner, Zeki, Basaran, Mert, Dizdar, Yavuz, Agaoglu, Fulya Yaman, Bilgic, Bilge, Sakar, Burak, Basaran, Gul Atalay, Darendeliler, Emin, Ozger, Harzem, Onat, Haluk, Bavbek, Sevil

“…Rhabdomyosarcoma (RMS) is rare disease in adults (age ≥ 16 years). The data from randomized prospective trials are scarce; the clinical outcome of these…”
Get full text

Ewing's Sarcoma of the Axial System in Patients Older Than 15 Years: Dismal Prognosis Despite Intensive Multiagent Chemotherapy and Aggressive Local Treatment by Argon, Andac, Basaran, Mert, Yaman, Fulya, Dizdar, Yavuz, Sakar, Burak, Camlica, Hakan, Bavbek, Sevil E., Ozger, Harzem, Darendeliler, Emin, Onat, Haluk

“…Background: Older age and axial location of Ewing's sarcoma have been reported as unfavorable prognostic factors. Methods: The records of patients older than…”
Get full text

Kanser hastasına yaklaşım: tanı, tedavi ve takipte sorunlar / Editörler, Haluk Onat, Nil Molinas Mandel by Onat, Haluk, Molinas Mandel, Nil

Get more information

Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma by Baujat, B, Audry, H, Bourhis, J, Chan, A T C, Onat, H, Chua, D T T, Kwong, D L W, Al-Sarraf, M, Chi, K H, Hareyama, M, Leung, S F, Thephamongkhol, K, Pignon, J P

“…A previous meta-analysis investigated the role of chemotherapy in head and neck locally advanced carcinoma. This work had not been performed on nasopharyngeal…”
Get more information

A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas by Basaran, Mert, Bavbek, E Sevil, Saglam, Sezer, Eralp, Levent, Sakar, Burak, Atalar, Ata Can, Bilgic, Bilge, Ozger, Harzem, Onat, Haluk

“…Osteosarcoma is a rare malignancy, and patients with this disease benefit from adjuvant chemotherapy. While cisplatin, anthracyclines and ifosfamide are the…”
Get more information

Prognostic factors in patients with aggressive non-Hodgkin's lymphoma without complete response to first-line therapy by Alici, Suleyman, Bavbek, Sevil, Basaran, Mert, Onat, Haluk

“…This study was conducted to retrospectively identify the prognostic factors that specifically predict survival rates of patients with aggressive non-Hodgkin's…”
Get full text

Chemoradiotherapy for localized non-Hodgkin's lymphoma: lessons from old studies by Basaran, Gul, Basaran, Mert, Onat, Haluk

Get full text

Correlation of HER 2/neu gene amplification with immunohistochemistry and other prognostic factors in breast carcinoma by Ramadan, Saime Sezgın, Yapicier, Ozlem, Kıhtır, Selçuk, Erdemır, Ayhan, Doğan, Tuğser Hakan, Uskent, Ismail, Onat, Haluk, Cakmakçi, Metin

“…The purpose of this study was to determine relationship between HER-2/neu status and estrogen receptor, progesterone receptor, grade and age by comparing…”
Get full text

Prognostic factors and survival in late adolescent and adult patients with small round cell tumors by ERALP, Yesim, BAVBEK, Sevil, BASARAN, Mert, KAYTAN, Esra, YAMAN, Fulya, BILGIC, Bilge, DARENDELILER, Emin, ONAT, Haluk

“…The primary objective of this study is to review the clinical characteristics of 25 patients in the adult and late adolescent age group, diagnosed and treated…”
Get full text

Prognostic factors in localized aggressive non-Hodgkin's lymphoma by ALICI, Sfileyman, BAVBEK, Sevil E, KAYTAN, Esra, ERALP, Yesim, ONAT, Haluk

“…To identify the prognostic factors that specifically predict survival rates of patients with localized aggressive non-Hodgkin's lymphoma (NHL), a retrospective…”
Get full text

Relapse of non‐Hodgkin's lymphoma confined to the corpus uteri by YAZAR, Aziz, BASARAN, Mert, YAMAN, Fulya, DIZDAR, Yavuz, TUZLALI, Sitki, BAVBEK, Sevil, ONAT, Haluk

Get full text

ANTIEMETIC EFFICACY OF DIAZEPAM IN THE PROPHYLAXIS OF ACUTE AND DELAYED EMESIS INDUCED BY CISPLATIN BASED CHEMOTHERAPY TREATED WITH STANDARD ANTIEMETICS by Dr. Pınar Sai̇p, Onat, Haluk, Uygun, Kazım, Dr. Cumhur Demi̇r Dr. Taflan Salepçi̇, Güney, Neşe, Başaran, Mert, Topuz, Erkan

“…Bu çalışma, sisplatinli kemoterapinin neden olduğu erken ve geç emezis tedavisinde diazepamın etkinliğini değerlendirmek için yapıldı. Çeşitli sisplatin (60-75…”
Get full text

Aggressive non-Hodgkin's lymphoma treated at the institute of oncology, Istanbul: Treatment, outcome, and prognostic factors by ALICI, Süleyman, BAVBEK, Sevil E, KAYTAN, Esra, BASARAN, Mert, ERALP, Yesim, ONAT, Haluk

“…In an unselected group of patients with aggressive non-Hodgkin's lymphoma (A-NHL) treated at our institution during a 10-year period (1989-1998), we studied…”
Get full text

Prognostic significance of marker half-life during chemotherapy in non-seminomatous germ cell testicular tumors by Inanç, S E, Meral, R, Darendeliler, E, Yasasever, V, Onat, H

“…Decrease in serum alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) levels is considered as a response during chemotherapy of non-seminomatous…”
Get more information

Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): A phase II study by BASARAN, Mert, BAVBEK, E. Sevil, SAKAR, Burak, ERALP, Yesim, ALICI, Süleyman, TAS, Faruk, YAMAN, Fulya, DOGAN, Öner, CAMLICA, Hakan, ONAT, Haluk

“…Epirubicin is an agent with a lower incidence of cardiotoxicity and myelotoxicity compared with doxorubicin; and it is active in patients with non-Hodgkin's…”
Get full text

Bcl-2 gene rearrangements and apoptosis rates in patients with Non-Hodgkin’s lymphoma during chemotherapy by Yazici, Hülya, Yalcinkaya, Leyla, Inanc, Sevil, Onat, Haluk, Saip, Pinar, Dalay, Nejat

“…Objectives: Overexpression of the bcl-2 gene as a result of the t(14,18) translocation leads to neoplastic transformation by suppressing apoptosis. However,…”
Get full text

Tartışmalı olgu by DEMİRELLİ, Fuat, ONAT, Haluk, TÜRKERİ, Levent, MOLINAS, Nil, ZORLU, Ferruk, İŞERİ, Cüneyt

Get full text